)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Seres Therapeutics
Seres Therapeutics (MCRB) investor relations material
Seres Therapeutics Status update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status update summary3 Mar, 2026
Leadership and Organizational Updates
Richard N. Kender appointed as Executive Chair and Interim CEO, bringing over 35 years of biopharma experience, including senior roles at Merck & Co.
Previous co-CEOs continue as Chief Legal Officer and Chief Financial Officer, ensuring leadership continuity.
Matthew Henn, Ph.D., becomes President in addition to Chief Scientific Officer; Kelly Brady, M.S., promoted to Chief Operating Officer.
Recent management transitions emphasize continuity and expertise in biotherapeutics.
Strategic Focus and Pipeline Developments
The organization is leveraging a proven scientific foundation to advance live biotherapeutic drugs for unmet medical needs, focusing on inflammatory and immune diseases, especially IBD and immune checkpoint-related enterocolitis (irEC).
SER-155 is being evaluated in a fully enrolled investigator-sponsored trial for irEC, with data expected in Q2 2026.
SER-155 is Phase 2 ready for allo-HSCT patients, with preparations complete and pending additional funding.
SER-603, a preclinical candidate for IBD, is in IND-enabling activities and positioned as a non-immunosuppressive therapy with significant commercial potential.
Development of an oral liquid LBP formulation based on SER-155 strains is progressing, supported by a CARB-X grant.
Financial Position and Operational Updates
Cash and cash equivalents stood at $45.8 million as of December 31, 2025, including $12.2 million raised in Q4 2025.
Cost reduction measures, including workforce reduction, have been implemented to extend the cash runway.
Current cash is expected to fund operations through Q3 2026, with ongoing efforts to secure further funding.
Future financial results and business updates will be communicated via press release; earnings calls will be discontinued.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Seres Therapeutics earnings date
Q4 202512 Mar, 2026
Seres Therapeutics
Next Seres Therapeutics earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Seres Therapeutics, Inc. is a microbiome therapeutics platform company that engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate which has completed Phase III clinical trial for the treatment of CDI. It also develops SER-155 and SER-287 which are in Phase Ib clinical trial to reduce incidences of gastrointestinal infections and ulcerative colitis; SER-301 that is in Phase Ib clinical trial to treat metastatic melanoma; and SER-262 to treat Clostridioides difficile infection.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage